Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: No evidence for its occurrence in the era of intensive insulin therapy

European Heart Journal

Volumn 28, Issue 20, 2007, Pages 2465-2471

  Konduracka, Ewa ^a   Gackowski, Andrzej ^a   Rostoff, Pawel ^a   Galicka Latala, Danuta ^a   Frasik, Wieslaw ^b   Piwowarska, Wieslawa ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Autopsy reports; Diabetic cardiomyopathy; Echocardiography; NT proBNP; Type 1 diabetes mellitus

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INSULIN;

ADULT; AGED; ARTICLE; AUTOPSY; CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE DURATION; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART MUSCLE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; SEX FACTORS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 35348951094     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm361     Document Type: Article

References (27)

1. Codinach Huix P, Freixa Pamias R. Diabetic cardiomyopathy: concept, heart function and pathogenesis. An Med Interna 2002;19:313-320.
2. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004;25:543- 567.
3. Rodrigues B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992;26:913-922.
4. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004;107:539- 557.
5. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602.
6. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974;229:1749-1754.
7. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:884-899.
8. Francis GS. Diabetic cardiomyopathy: fact or fiction? Heart 2001;85:247-248.
9. Berkova M, Opavsky J, Berka Z, Skrańka V, Salinger J. Left ventricular diastolic filling in young persons with type 1 diabetes mellitus. Biomedical Papers 2003;147:57-61.
10. Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab 2003;29:455-466.
11. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994;17:633-639.
12. Rajput R, Jagdish, Siwach SB, Rattan A. Echocardiographic and Doppler assessment of cardiac functions in patients of non-insulin dependent diabetes mellitus. JIACM 2002;3:164-168.
13. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105:1387-1393.
14. Mottram PM, Marwick TH. Assessment of diastolic function: what the general cardiologist needs to know. Heart 2005;91:681-695.
15. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 2006;175:611-617.
16. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-422.
17. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-1579.
18. Anderson B. Doppler assessment of left ventricular systolic and diastolic function. In: Anderson B, ed. Echocardiography: The Normal Examination and Echocardiographic Measurements. MGA Graphics; 2002. p189-227.
19. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
20. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O'Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996;9:736-760.
21. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-1533.
22. Sohn DW, Chai IH, Lee DJ, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-480.
23. Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res 2003;57:312-319.
24. Warley A, Powell MJ, Skepper JN. Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats. Diabetologia 1983;38:413-421.
25. Thompson EW. Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatment. Am J Anat 1988;182:270- 282.
26. Rota M, Lecapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G, Vitale S, Urbanek K, Casarsa C, Giorgio M, Luscher TF, Pelicci PG, Anversa P, Leri A, Kajsutra J. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 2006;99:1-2.
27. Kang P, Izumo S. Apoptosis and heart failure. A critical review of the literature. Circ Res 2000;86:1107-1113.